Compare AUXX & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUXX | EIKN |
|---|---|---|
| Founded | N/A | 2019 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.2M | 631.0M |
| IPO Year | 2026 | 2026 |
| Metric | AUXX | EIKN |
|---|---|---|
| Price | $5.83 | $8.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.60 |
| AVG Volume (30 Days) | 7.9K | ★ 489.4K |
| Earning Date | N/A | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.69 | $7.90 |
| 52 Week High | $5.94 | $16.50 |
| Indicator | AUXX | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.36 |
| Support Level | N/A | $8.43 |
| Resistance Level | N/A | $10.20 |
| Average True Range (ATR) | 0.00 | 0.78 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 0.00 | 17.23 |
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.